CIPLA
Back to All Ratios
|
CIPLA Last 5 Year EV/CE History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EV/CE(x) | 2.82 | 3.70 | 4.45 | 2.99 | 3.74 |
What is the latest EV/CE ratio of CIPLA ?
| Year | EV/CE |
|---|---|
| Mar2026 | 2.82 |
| Mar2025 | 3.70 |
| Mar2024 | 4.45 |
| Mar2023 | 2.99 |
| Mar2022 | 3.74 |
How is EV/CE of CIPLA Trending?
| Years | EV/CE | % Change | |
|---|---|---|---|
| Mar2026 | 2.82 | -23.78 | |
| Mar2025 | 3.7 | -16.85 | |
| Mar2024 | 4.45 | 48.83 | |
| Mar2023 | 2.99 | -20.05 | |
| Mar2022 | 3.74 | - | |
Other Financial Ratios of CIPLA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,187.3 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
| MANKIND PHARMA | ₹98,270.3 Cr | 0.9% | -1.2% | 0.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0% |
4.7% |
-8% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses